Roundhill Magnificent Seven ETF vs MiniMed Group Inc. Common Stock — how do they compare? Roundhill Magnificent Seven ETF trades at $73.67 (market cap $5.78B), while MiniMed Group Inc. Common Stock trades at $19.53 (market cap $5.57B). The key difference: Roundhill Magnificent Seven ETF and MiniMed Group Inc. Common Stock are close in size by market cap, and Roundhill Magnificent Seven ETF is trading nearer its 52-week high, MiniMed Group Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Roundhill Magnificent Seven ETF for 36 Days and MiniMed Group Inc. Common Stock for 1 Days on average.
| MAGS | MMED | |
|---|---|---|
Market Cap | $5.78B | $5.57B |
Volume | 4,410,665 | 23,336,073 |
Sector | Sector/Thematic | Health |
52-Week High | $73.90 | $23.84 |
52-Week Low | $55.39 | $10.80 |
Typical Hold Time | 36 Days | 1 Days |
Enterprise Value | — | $5.37B |
Signals from Pluang's Aura AI — not financial advice
MAGS (Roundhill Magnificent Seven ETF) trades at $73.63, down slightly by 0.08% with a bullish technical signal from moving averages. The ETF provides equal-weighted exposure to seven mega-cap tech leaders, though it has underperformed the broader market in 2026 with only 2% year-to-date gains. Recent news highlights ongoing investor debate about the Magnificent Seven's leadership role amid shifting AI investment trends.
The ETF faces near-term pressure from underperformance versus the S&P 500 but maintains long-term growth potential through diversified tech exposure. Key risks include concentration in seven stocks and market rotation away from mega-caps, while the bullish technical setup suggests potential for near-term recovery if AI momentum continues.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
MAGS is an ETF that provides concentrated exposure to the seven technology-focused mega-cap companies often referred to as the 'Magnificent Seven' (Alphabet, Amazon, Apple, Meta, Microsoft, NVIDIA, and Tesla). The fund is designed to capture the performance of these market-leading stocks, which have been the primary drivers of market returns. It offers a simple way for investors to invest solely in this select group of high-growth technology companies.
Read more on MAGS →MiniMed develops, manufactures, and markets diabetes-management technologies. Its products include insulin-delivery systems, continuous glucose monitors, smart insulin pens, and related software.
Read more on MMED →